Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BELLUS Health (TSE:BLU)
TSX:BLU
BELLUS Health (BLU) Stock Price & Analysis
74 Followers
BLU Stock Chart & Stats
Day’s RangeC$19.24 - C$19.61
52-Week Range― - ―
Previous CloseC$19.5
Volume28.67K
Average Volume (3M)N/A
Market Cap
C$2.47B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$20.23Price Target Upside3.88% Upside
Rating ConsensusHold
Number of Analyst Covering5
BELLUS Health News
PremiumPre-Earnings
Is BLU a Buy, Before Earnings?
BLU FAQ
What was BELLUS Health’s price range in the past 12 months?
Currently, no data Available
What is BELLUS Health’s market cap?
Currently, no data Available
When is BELLUS Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BELLUS Health’s earnings last quarter?
Currently, no data Available
Is BELLUS Health overvalued?
According to Wall Street analysts BELLUS Health’s price is currently Undervalued.
Does BELLUS Health pay dividends?
BELLUS Health does not currently pay dividends.
What is BELLUS Health’s EPS estimate?
BELLUS Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BELLUS Health have?
Currently, no data Available
What happened to BELLUS Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BELLUS Health?
Among the largest hedge funds holding BELLUS Health’s share is RA Capital Management. It holds BELLUS Health’s shares valued at 91M.
---
BELLUS Health Stock Smart Score
Company Description
BELLUS Health
BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
---
BLU Stock 12 Months Forecast
Average Price Target
C$20.23
▲(3.88% Upside)
BioLife Solutions
―
Corbus Pharmaceuticals
―
Crispr Therapeutics AG
―
Gritstone Oncology
―
―
Best Analysts Covering BLU
1 Year
1 Year Success Rate
8/8 ratings generated profit
1 Year Average Return
+48.71%
reiterated a buy rating a year ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +48.71% per trade.
---